Commentary on "Meta-analysis of six-month memantine trials in Alzheimer's disease." Memantine has negligible benefits in mild to moderate Alzheimer's disease.
Alzheimers Dement. 2007 Jan;3(1):21-2.
Please login to recommend the paper.
To make a comment you must login or register.
No Available Comments